Posts Tagged ‘chemoradiotherapy’

Adjuvant chemoradiotherapy significantly improves survival of patients with resectable pancreatic cancer, according to medical records of almost 3,000 patients.

Chemoradiotherapy extended median survival by more than 30% compared with surgical resection only, researchers reported in the January Archives of Surgery.

In a multivariate analysis, adjuvant chemoradiotherapy proved to be one of only three predictors of improved survival, the other two being treatment at high-volume and academic centers.

“This analysis provides strong evidence in a real-world setting that postoperative chemoradiotherapy and possibly adjuvant radiotherapy alone improve clinical outcome in patients with pancreatic cancer,” Relin Yang, MD, of the University of Miami, and colleagues wrote. (more…)


Read Full Post »